Cargando…
Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach
OBJECTIVE: Vaccines are utilized to prevent the severity of illnesses like the COVID-19 virus. Currently, there are a lot of COVID-19 vaccines available in the market like Pfizer, Moderna, AstraZeneca, Johnson and Johnson, and Sinovac. This research aimed to analyze the preference on the existing va...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293378/ https://www.ncbi.nlm.nih.gov/pubmed/35874794 http://dx.doi.org/10.1016/j.puhip.2022.100300 |
_version_ | 1784749616832446464 |
---|---|
author | Ong, Ardvin Kester S. Prasetyo, Yogi Tri Lagura, Fae Coleen Ramos, Rochelle Nicole Salazar, Jose Ma Luis Sigua, Keenan Mark Villas, Jomy Anne Chuenyindee, Thanatorn Nadlifatin, Reny Persada, Satria Fadil Thana, Kriengkrai |
author_facet | Ong, Ardvin Kester S. Prasetyo, Yogi Tri Lagura, Fae Coleen Ramos, Rochelle Nicole Salazar, Jose Ma Luis Sigua, Keenan Mark Villas, Jomy Anne Chuenyindee, Thanatorn Nadlifatin, Reny Persada, Satria Fadil Thana, Kriengkrai |
author_sort | Ong, Ardvin Kester S. |
collection | PubMed |
description | OBJECTIVE: Vaccines are utilized to prevent the severity of illnesses like the COVID-19 virus. Currently, there are a lot of COVID-19 vaccines available in the market like Pfizer, Moderna, AstraZeneca, Johnson and Johnson, and Sinovac. This research aimed to analyze the preference on the existing vaccine attributes of COVID-19. STUDY DESIGN: Specifically, this study considered 7 attributes such as cost, brand, recommendations, efficacy, side effects, vaccine type, and dose. METHODS: A conjoint analysis with orthogonal design was utilized and 865 respondents were participated. RESULTS: The result showed that consumers considered brand as the highest attribute, specifically Pfizer and Moderna among other brands. Moreover, the efficacy of 90% and higher were the preferred vaccine with 1 in 100 patient side effects reported. It was seen that safety and effectiveness is the priority in choosing a COVID-19 vaccine. Interestingly, the knowledge and understanding of the COVID-19 vaccine was found to drive consumer's preference for the vaccines available. CONCLUSIONS: The findings of this study could be utilized by the government to increase the willingness to be vaccinated. Lastly, the result of this study would pave a way to promote herd immunity to help fight the COVID-19 pandemic worldwide. |
format | Online Article Text |
id | pubmed-9293378 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-92933782022-07-19 Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach Ong, Ardvin Kester S. Prasetyo, Yogi Tri Lagura, Fae Coleen Ramos, Rochelle Nicole Salazar, Jose Ma Luis Sigua, Keenan Mark Villas, Jomy Anne Chuenyindee, Thanatorn Nadlifatin, Reny Persada, Satria Fadil Thana, Kriengkrai Public Health Pract (Oxf) Original Research OBJECTIVE: Vaccines are utilized to prevent the severity of illnesses like the COVID-19 virus. Currently, there are a lot of COVID-19 vaccines available in the market like Pfizer, Moderna, AstraZeneca, Johnson and Johnson, and Sinovac. This research aimed to analyze the preference on the existing vaccine attributes of COVID-19. STUDY DESIGN: Specifically, this study considered 7 attributes such as cost, brand, recommendations, efficacy, side effects, vaccine type, and dose. METHODS: A conjoint analysis with orthogonal design was utilized and 865 respondents were participated. RESULTS: The result showed that consumers considered brand as the highest attribute, specifically Pfizer and Moderna among other brands. Moreover, the efficacy of 90% and higher were the preferred vaccine with 1 in 100 patient side effects reported. It was seen that safety and effectiveness is the priority in choosing a COVID-19 vaccine. Interestingly, the knowledge and understanding of the COVID-19 vaccine was found to drive consumer's preference for the vaccines available. CONCLUSIONS: The findings of this study could be utilized by the government to increase the willingness to be vaccinated. Lastly, the result of this study would pave a way to promote herd immunity to help fight the COVID-19 pandemic worldwide. Elsevier 2022-07-19 /pmc/articles/PMC9293378/ /pubmed/35874794 http://dx.doi.org/10.1016/j.puhip.2022.100300 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Original Research Ong, Ardvin Kester S. Prasetyo, Yogi Tri Lagura, Fae Coleen Ramos, Rochelle Nicole Salazar, Jose Ma Luis Sigua, Keenan Mark Villas, Jomy Anne Chuenyindee, Thanatorn Nadlifatin, Reny Persada, Satria Fadil Thana, Kriengkrai Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach |
title | Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach |
title_full | Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach |
title_fullStr | Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach |
title_full_unstemmed | Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach |
title_short | Young adult preference analysis on the attributes of COVID-19 vaccine in the Philippines: A conjoint analysis approach |
title_sort | young adult preference analysis on the attributes of covid-19 vaccine in the philippines: a conjoint analysis approach |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293378/ https://www.ncbi.nlm.nih.gov/pubmed/35874794 http://dx.doi.org/10.1016/j.puhip.2022.100300 |
work_keys_str_mv | AT ongardvinkesters youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach AT prasetyoyogitri youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach AT lagurafaecoleen youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach AT ramosrochellenicole youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach AT salazarjosemaluis youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach AT siguakeenanmark youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach AT villasjomyanne youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach AT chuenyindeethanatorn youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach AT nadlifatinreny youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach AT persadasatriafadil youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach AT thanakriengkrai youngadultpreferenceanalysisontheattributesofcovid19vaccineinthephilippinesaconjointanalysisapproach |